Drug intelligence / Profile preview

leptin

Development stage
Phase 3
Lead developer
The Rockefeller University
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

Leptin is a protein hormone primarily produced by adipose (fat) tissue that plays a central role in regulating energy homeostasis, appetite, and metabolism. It acts as an appetite suppressant by signaling the hypothalamus in the brain to reduce food intake and increase energy expenditure. Leptin binds to its receptor (leptin receptor/ObR), which belongs to the class I cytokine family of receptors. The main intracellular signaling pathways activated by leptin include JAK-STAT, PI3K, ERK/MAPK, and mTOR. These pathways mediate effects on neuroendocrine function, immune regulation (including modulation of T lymphocyte responses), inflammation control via cytokine production (e.g., IL-1RA, IL-6, TNF-alpha), and metabolic processes such as glucose homeostasis and lipid metabolism[2][6][8]. Leptin deficiency or resistance can lead to increased appetite and severe metabolic disturbances; recombinant analogs like metreleptin are used therapeutically for congenital or acquired generalized lipodystrophy[1][5].

Other names
OB proteinobesity factorsatiety hormone
02

Targets

LEPR (Leptin receptor)

Beyond the preview

Go deeper on leptin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on leptin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call